Volume 374| Issue 6566| 22 Oct 2021
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
BY Jose Mateus et al.
22 Oct 2021
A reduced dose of the Moderna SARS-CoV-2 vaccine induces long-lived T cell and antibody responses comparable to natural infection.